About Heidelberg Epignostix
Heidelberg Epignostix is a healthcare company whose mission is to transform cancer diagnostics through data science. The company has developed novel AI-based bioinformatics algorithms with utility in cancer classification for improved accuracy in cancer diagnosis, prognosis and therapy management. The lead product, the Heidelberg Brain Classifier, is currently available as a research-use-only resource. Heidelberg Epignostix is located in Heidelberg, Germany. For more information visit www.epignostix.com.
Press releases
Press
DKFZ spin-off Epignostix raises €4.3m Seed round to commercialize diagnostic tumor classifier
Heidelberg Epignostix GmbH, a deeptech start-up committed to precision cancer diagnostics today announces €4.3M in seed funding. This investment will enable Heidelberg Epignostix to make a substantial leap forward in driving market development for its flagship indication for brain tumor classification.
CARMA FUND I Capital GmbH & Co KG led the round with participation from High-Tech Gründerfonds, LBBW Venture Capital GmbH and Start-up BW Seed Fonds. Heidelberg Epignostix’ technol
Info & Contact
- Web:
- epignostix.com
Address
Heidelberg Epignostix GmbH
Köpfelweg 58
69118 Heidelberg
Köpfelweg 58
69118 Heidelberg
In portfolio
20. Jun 2024
Sector
Dr. Katharina Severin
Investment Manager